Danielle Moulia - Concepedia

Author

Danielle Moulia

Stanford University

Also Known As

Danielle L. Moulia, Danielle L. Moulia, Danielle Moulia, Nancy Messonnier

Publications

Citations

H-Index

Concepts

All Affiliations

Stanford University University of Washington Kaiser Permanente National Center for Immunization and Respiratory Diseases Vanderbilt University

About

Danielle Moulia is an author at Stanford University specializing in public health, medicine, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	959
2	Public Health	10	10	959
3	Epidemiology	8	8	762
4	Emergency Medicine	1	1	43
5	Health Informatics	1	1	43

Danielle Moulia

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 Julia W. Gargano, Megan Wallace, Stephen C. Hadler, MMWR Morbidity and Mortality Weekly Report	2021	593
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States Nicholas P. Deputy, Joseph Deckert, Anna N. Chard, New England Journal of Medicine	2023	288
Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019 David A. Siegel, Tara C. Jatlaoui, Emily H. Koumans, MMWR Morbidity and Mortality Weekly Report	2019	260
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Katherine E. Fleming-Dutra, Jefferson M. Jones, Lauren E. Roper, MMWR Morbidity and Mortality Weekly Report	2023	237
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 Hannah G. Rosenblum, Stephen C. Hadler, Danielle Moulia, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesImmunologyCovid-19 VaccinesAdvisory CommitteeVaccine Hesitancy	2021	206
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 Jessica R. MacNeil, John R. Su, Karen R. Broder, MMWR Morbidity and Mortality Weekly Report	2021	182
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021 Sarah Mbaeyi, Sara E. Oliver, Jennifer P. Collins, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesImmunologyCovid-19 VaccinesAdvisory CommitteeVaccine Hesitancy	2021	173
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023 Alexandra F. Dalton, Alpha Oumar Diallo, Anna N. Chard, MMWR Morbidity and Mortality Weekly Report	2023	170
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 Kate R. Woodworth, Danielle Moulia, Jennifer P. Collins, MMWR Morbidity and Mortality Weekly Report	2021	167
Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021 Elizabeth M. Painter, Emily N. Ussery, Anita Patel, MMWR Morbidity and Mortality Weekly Report	2021	156

Page 1